Squarepoint Ops LLC Reata Pharmaceuticals Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $2.02 Million - $6.1 Million	-65,515 Reduced 73.38%	23,769 $2.16 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $1.06 Million - $2.02 Million	48,065 Added 116.61%	89,284 $3.39 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $350,234 - $658,425	18,044 Added 77.86%	41,219 $1.04 Million
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $479,954 - $845,887	23,175 New	23,175 $704,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $1.8 Million - $2.96 Million	-74,679 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $1.4 Million - $6.07 Million	54,683 Added 273.47%	74,679 $1.97 Million
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $1.31 Million - $1.87 Million	13,052 Added 187.96%	19,996 $2.01 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $52,519 - $101,515	-671 Reduced 8.81%	6,944 $983,000
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $481,806 - $678,924	5,112 Added 204.23%	7,615 $759,000
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $255,381 - $462,103	2,503 New	2,503 $309,000
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $621,787 - $1.09 Million	-6,648 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $839,642 - $1.17 Million	6,648 New	6,648 $1.04 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $2.45 Million - $4.89 Million	-19,751 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $1.17 Million - $3.43 Million	15,732 Added 391.44%	19,751 $4.04 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $248,056 - $333,305	-3,481 Reduced 46.41%	4,019 $323,000
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $161,657 - $196,248	-2,080 Reduced 21.71%	7,500 $708,000
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $572,197 - $1.12 Million	-11,025 Reduced 53.51%	9,580 $819,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $397,637 - $623,368	8,155 Added 65.5%	20,605 $1.16 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $443,718 - $1.15 Million	12,450 New	12,450 $1.02 Million
Q2 2018 Aug 14, 2018	SELL	$19.94 - $40.96 $658,020 - $1.35 Million	-33,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$20.0 - $30.19 $351,320 - $530,317	17,566 Added 113.81%	33,000 $677,000
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $345,567 - $513,489	15,434	15,434 $437,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account